|
AU2018326439A1
|
|
Protransduzin-D - improved enhancer of gene transfer
|
|
CN109963863A
|
|
Promote transducin-C(Protransducine-C): gene transfer activity factor
|
|
WO2016131962A1
|
|
Polypeptide with activity against diphtheria toxin
|
|
WO2016079143A1
|
|
Viral hepatitis c infection inhibitor
|
|
CN111875670A
|
|
Peptides having antagonistic activity against native CXCR4
|
|
AU2014261381A1
|
|
Protransduzin B, a gene transfer enhancer
|
|
WO2013060887A1
|
|
A polypeptide for the protection against heart ischemia-reperfusion injury
|
|
US2014336118A1
|
|
Polypeptide for the protection against heart ischemia-reperfusion injury
|
|
CN103764674A
|
|
Process for preparing human relaxin-2
|
|
WO2009034134A2
|
|
Use of natriuretic peptides for treating angioedema syndromes
|
|
WO2009019254A1
|
|
Igfbp-2 c-terminal fragments and uses thereof
|
|
EP2078530A1
|
|
Use of natriuretic peptides for treating angioedema syndromes
|
|
EP2071024A1
|
|
Peptides of human prostatic acid phosphatase enhancing viral infectivity
|
|
DE102007030904A1
|
|
Human circulating antiviral albumin fragment (ALB-408) and its use
|
|
US2009082262A1
|
|
Processed human chemokines PHC-1 and PHC-2
|
|
WO2006003209A1
|
|
Use of uteroglobin as a marker for human oncological and infectious diseases
|
|
EP1023445A1
|
|
Cadherin derived growth factor and the application thereof
|
|
US6849593B1
|
|
Bifidogenic peptides
|
|
EP0907736A2
|
|
Cc-type chemokines
|
|
EP0783522A1
|
|
PEPTIDES FROM THE hPTH SEQUENCE (1-37)
|
